Capital Square, LLC Organogenesis Holdings Inc. Transaction History
Capital Square, LLC
- $181 Million
- Q2 2025
A detailed history of Capital Square, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Capital Square, LLC holds 22,500 shares of ORGO stock, worth $101,925. This represents 0.05% of its overall portfolio holdings.
Number of Shares
22,500
Previous 23,100
2.6%
Holding current value
$101,925
Previous $99,000
17.17%
% of portfolio
0.05%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding ORGO
# of Institutions
123Shares Held
71.9MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...